Validation of a new classifier for the automated analysis of the human epidermal growth factor receptor 2 (HER2) gene amplification in breast cancer specimens

Diagnostic Pathology

Volumn 8, Issue 1, 2013, Pages

  Furrer, Daniela ^a   Jacob, Simon ^a,b   Caron, Chantal ^a,b   Sanschagrin, François ^a,b   Provencher, Louise ^a,b   Diorio, Caroline ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Accuracy; Breast cancer; Fluorescence in situ hybridization (FISH); HER2; Image analysis; Nuclei analysis; Nuclei sampling analysis; Tile sampling analysis; Trastuzumab

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERBB2 PROTEIN, HUMAN; TUMOR MARKER;

ALGORITHM; ARTICLE; AUTOMATED PATTERN RECOGNITION; BREAST TUMOR; COMPARATIVE STUDY; COMPUTER PROGRAM; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LABORATORY AUTOMATION; PHENOTYPE; PREDICTIVE VALUE; PROGNOSIS; REPRODUCIBILITY; SIGNAL PROCESSING; VALIDATION STUDY;

ALGORITHMS; AUTOMATION, LABORATORY; BREAST NEOPLASMS; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; PATTERN RECOGNITION, AUTOMATED; PHENOTYPE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECEPTOR, ERBB-2; REPRODUCIBILITY OF RESULTS; SIGNAL PROCESSING, COMPUTER-ASSISTED; SOFTWARE DESIGN; TUMOR MARKERS, BIOLOGICAL;

MLCS; MLOWN;

EID: 84873131849     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-8-17     Document Type: Article

References (21)

1. Rubin I, Yarden Y. The basic biology of HER2. Ann Oncol 2001, 12(Suppl 1):S3-S8. 10.1093/annonc/12.suppl_1.S3, 11804381.
2. Soerjomataram I, Louwman MW, Ribot JG, Roukema JA, Coebergh JW. An overview of prognostic factors for long-term survivors of breast cancer. Breast Cancer Res Treat 2008, 107(3):309-330. 10.1007/s10549-007-9556-1, 2217620, 17377838.
3. Gianni L, Dafni U, Gelber RD, Azambuja E, Muehlbauer S, Goldhirsch A, Untch M, Smith I, Baselga J, Jackisch C, et al. Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial. Lancet Oncol 2011, 12(3):236-244. 10.1016/S1470-2045(11)70033-X, 21354370.
4. Piccart-Gebhart MJ, Procter M, Leyland-Jones B, Goldhirsch A, Untch M, Smith I, Gianni L, Baselga J, Bell R, Jackisch C, et al. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med 2005, 353(16):1659-1672. 10.1056/NEJMoa052306, 16236737.
5. Hanna W, O'Malley FP, Barnes P, Berendt R, Gaboury L, Magliocco A, Pettigrew N, Robertson S, Sengupta S, Tetu B, et al. Updated recommendations from the Canadian National Consensus Meeting on HER2/neu testing in breast cancer. Curr Oncol 2007, 14(4):149-153. 10.3747/co.2007.131, 1948868, 17710207.
6. Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 2007, 25(1):118-145.
7. Ross JS, Linette GP, Stec J, Clark E, Ayers M, Leschly N, Symmans WF, Hortobagyi GN, Pusztai L. Breast cancer biomarkers and molecular medicine. Expert Rev Mol Diagn 2003, 3(5):573-585. 10.1586/14737159.3.5.573, 14510178.
8. Stevens R, Almanaseer I, Gonzalez M, Caglar D, Knudson RA, Ketterling RP, Schrock DS, Seemayer TA, Bridge JA. Analysis of HER2 gene amplification using an automated fluorescence in situ hybridization signal enumeration system. J Mol Diagn 2007, 9(2):144-150. 10.2353/jmoldx.2007.060102, 1867448, 17384205.
9. Tubbs RR, Pettay JD, Swain E, Roche PC, Powell W, Hicks DG, Grogan T. Automation of manual components and image quantification of direct dual label fluorescence in situ hybridization (FISH) for HER2 gene amplification: a feasibility study. Appl Immunohistochem Mol Morphol 2006, 14(4):436-440. 10.1097/01.pai.0000213101.26193.f1, 17122642.
10. Lörch T, Piper J, Tomisek JD. "Tile sampling": a new method for the automated quantitative analysis of samples with high cell density and its application to Her2 scanning. Proceedings of the Third Euroconference on Quantitative Molecular Cytogenetics: July 4-6 2002 2002, 9-14. Stockholm, Sweden: Rosenön.
11. Theodosiou Z, Kasampalidis IN, Karayannopoulou G, Kostopoulos I, Bobos M, Bevilacqua G, Aretini P, Starita A, Lyroudia K, Pitas I. Evaluation of FISH image analysis system on assessing HER2 amplification in breast carcinoma cases. Breast 2008, 17(1):80-84. 10.1016/j.breast.2007.07.041, 17889539.
12. Kayser K, Schultz H, Goldmann T, Gortler J, Kayser G, Vollmer E. Theory of sampling and its application in tissue based diagnosis. Diagn Pathol 2009, 4:6. 10.1186/1746-1596-4-6, 2649041, 19220904.
13. Piper J, Lörch T, Poole I, Tomisek JD. Computing the Her2:CEP-17 ratio of tumor cells in breast cancer tissue sections by analysis of the FISH spot counts of a tiles sampling. Proceedings of the Third Euroconference on Quantitative Molecular Cytogenetics: July 4-6 2002 2002, 54-59. Stockholm, Sweden: Rosenön.
14. Markiewicz T. Using MATLAB software with Tomcat server and Java platform for remote image analysis in pathology. Diagn Pathol 2011, 6(Suppl 1):S18. 10.1186/1746-1596-6-S1-S18, 3073211, 21489188.
15. Ellis CM, Dyson MJ, Stephenson TJ, Maltby EL. HER2 amplification status in breast cancer: a comparison between immunohistochemical staining and fluorescence in situ hybridisation using manual and automated quantitative image analysis scoring techniques. J Clin Pathol 2005, 58(7):710-714. 10.1136/jcp.2004.023424, 1770709, 15976337.
16. Kayser K, Radziszowski D, Bzdyl P, Sommer R, Kayser G. Towards an automated virtual slide screening: theoretical considerations and practical experiences of automated tissue-based virtual diagnosis to be implemented in the Internet. Diagn Pathol 2006, 1:10. 10.1186/1746-1596-1-10, 1524814, 16764733.
17. Kayser K, Gortler J, Goldmann T, Vollmer E, Hufnagl P, Kayser G. Image standards in tissue-based diagnosis (diagnostic surgical pathology). Diagn Pathol 2008, 3:17. 10.1186/1746-1596-3-17, 2362107, 18423031.
18. Pantanowitz L, Valenstein PN, Evans AJ, Kaplan KJ, Pfeifer JD, Wilbur DC, Collins LC, Colgan TJ. Review of the current state of whole slide imaging in pathology. J Pathol Inform 2011, 2:36. 10.4103/2153-3539.83746, 3162745, 21886892.
19. Kayser K, Kayser G. Virtual microscopy and automated diagnosis. Virtual microscopy and virtual slides in teaching, diagnosis and research 2005, Boca Raton: Taylor & Francis, Gu J, Ogilvie R.
20. Florell SR, Smoller BR, Boucher KM, Grossman D, Harris RM, Bowen GM, Leachman SA. Sampling of melanocytic nevi for research purposes: a prospective, pilot study to determine effect on diagnosis. J Am Acad Dermatol 2008, 59(5):814-821. 10.1016/j.jaad.2008.07.020, 19119097.
21. Gortler J, Berghoff M, Kayser G, Kayser K. Grid technology in tissue-based diagnosis: fundamentals and potential developments. Diagn Pathol 2006, 1:23. 10.1186/1746-1596-1-23, 1564417, 16930477.